Animal Growth Promoters and Performance Enhancers Market Share, Size, Trends Analysis, Industry Forecast 2030

Animal Growth Promoters and Performance Enhancers Market Size, Share & Trends Analysis By Product, By Type, By Application, By disease indication By, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Animal Growth Promoters and Performance Enhancers Market Size, Share & Trends Analysis By Product, By Type, By Application, By disease indication By, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Published: Mar 2022 Report ID: BIOT2210 Pages: 1 - 245 Formats*:     
Category : Biotechnology
Global Animal Growth Promoters and Performance Enhancers Market Overview:

According to SPER Market Research, the Animal Growth Promoters and Performance Enhancers Market is estimated to reach USD 26.1 billion by 2030 with a CAGR of 6.1%. The drugs and chemicals used for the enhancement of productivity, that helps in the easy digestion of foods and faster growth are called the animal growth promoters and performance enhancers. Increasing the demand for natural growth promoters, growing animal epidemics, climate change, livestock-based products, and animal consumption; these are the key factors for the expansion of this market.

Impact of COVID-19 on the Animal Growth Promoters and Performance Enhancers Market 
People with confirmed infections limit contact with animals, while handling pets or animals should take precautions, because animals and humans occasionally share diseases. Key players in the market have adopted several methods to deal with this turbulence. A negative blow on market augmentation is due to the decline in the veterinary manufacturing facility, manufactured goods unavailability and held back supply chains.

Scope of the report:
 Report Metric Details
 Market size available for years 2019-2030
 Base year considered 2021
 Forecast period 2022-2030
 Segments coveredBy Product, By Application, By Type, By Disease Indication, By Region
 Geographies covered North America, Europe, Asia Pacific, Latin America , Middle East, Africa
 Companies CoveredAlltech Corporation, Archer-Daniels-Midland, Company (ADM), Associated British Foods plc, BASF SE, Biomin Holding GmbH, Bluestar Adisseo Company, Boehringer Ingelheim Group, Bupo Animal Health Pty Ltd., Cargill, Incorporated, Chr. Hansen, Elanco Animal Health, Incorporated, Erber AG, Evonik Industries AG, Guangdong VTR Bio-Tech Co., Ltd., Kemin Industries, Inc, Lallemand Inc., Land O’Lakes, Inc., Merck & Co., Inc, Novozymes A/S, Novus International, Inc., Nutreco N.V., Phibro Animal Health, Corporation, Royal DSM N.V., Vetoquinol S.A., Zoetis Inc.
Drivers: increase in the demand for naturally produced growth promoters:
Alternative positive method to reduce use of antibiotics, the rising demand for organic products, breeding animals for robustness and health, good weaning practices, high-welfare animal farming; these are the keys for the growth of natural promoters.

Challenges: rising threat of disease transmission to and from agricultural animals:
Increase in disease transmission is projected to create a challenge to this market expansion.



Opportunities: Focus on growing environmental sustainability:
Environmental friendly animal growth promoters are likely to offer massive growth opportunities in this market.

Global Animal Growth Promoters and Performance Enhancers Market Segmentation:

By Type: Based on the Type, Animal Growth Promoters and Performance Enhancers Market segmented as; Antibiotic growth promoters and performance enhancers, Non-antibiotic growth promoters and performance enhancers.

By Animal Type: Based on the Animal Type, Animal Growth Promoters and Performance Enhancers Market segmented as; Aquaculture, Livestock, Poultry, Swine, Other Animals.

By Region: The Asia Pacific region owns the biggest share of the market; this is because of to the giant population generating superior domestic meat demand, animal products industry, relatively undisturbed regulatory scenario, and government efforts to promote animal producers.

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact on the Animal Growth Promoters and Performance Enhancers Market
4.4. Market Trends

5. Global Animal Growth Promoters and Performance Enhancers Market, by Type, 2019-2030 (USD Million)
5.1. Antibiotic growth promoters and performance enhancers
5.2. Non-antibiotic growth promoters and performance enhancers

6. Global Animal Growth Promoters and Performance Enhancers Market, by Animal Type, 2019-2030 (USD Million)
6.1. Aquaculture
6.2. Livestock
6.3. Poultry
6.4. Swine
6.5. Other Animals

7. Global Animal Growth Promoters and Performance Enhancers Market, by Region, 2019-2030 (USD Million)
7.1. North America
7.1.1. US
7.1.2. Canada
7.2. Europe
7.2.1. France 
7.2.2. Germany 
7.2.3. Italy 
7.2.4. Spain 
7.2.5. Rest of the Europe
7.3. Asia Pacific 
7.3.1. China
7.3.2. India 
7.3.3. Japan
7.3.4. Rest of Asia Pacific
7.4. Latin America
7.5. Middle East 
7.6. Africa

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis, By Key Players 
8.3. Competitive Scenario 
8.3.1. Product Launches
8.3.2. Partnerships, Collaborations and Agreements
8.3.3. Acquisitions
8.3.4. Expansions
8.3.5. Other Developments

9. Company Profiles
9.1. Alltech Corporation
9.2. Archer-Daniels-Midland Company (ADM)
9.3. Associated British Foods plc 
9.4. BASF SE 
9.5. Biomin Holding GmbH 
9.6. Bluestar Adisseo Company 
9.7. Boehringer Ingelheim Group 
9.8. Bupo Animal Health Pty Ltd. 
9.9. Cargill, Incorporated 
9.10. Chr. Hansen
9.11. Elanco Animal Health Incorporated 
9.12. Erber AG
9.13. Evonik Industries AG
9.14. Guangdong VTR Bio-Tech Co., Ltd.
9.15. Kemin Industries, Inc 
9.16. Lallemand Inc. 
9.17. Land O’Lakes, Inc. 
9.18. Merck & Co., Inc
9.19. Novozymes A/S
9.20. Novus International, Inc. 
9.21. Nutreco N.V. 
9.22. Phibro Animal Health Corporation 
9.23. Royal DSM N.V. 
9.24. Vetoquinol S.A. 
9.25. Zoetis Inc. 

10. Appendix


SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Not able to find what you are looking for? Need customization in the existing report?
Click Here
PLACE AN ORDER
  • 15% off
     
    $ 4250
  • 20% off
             
    $ 5650
  • 25% off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
CALL OR EMAIL US
US:
India:
Email:
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-SIEMENS
SPER-IQVIA
SPER-Pfizer
SPER-LOREAL
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-IPSOS
SPER-Heineken

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]

 +91-742-898-5650